Screener
Boston Scientific BSX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Boston Scientific’s reported figures.
Based on the most recent quarter.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
FAQ
- What is Boston Scientific's debt-to-equity?
- Boston Scientific (BSX) reported debt-to-equity of 0× in Q4 2025.
- How has Boston Scientific's debt-to-equity changed year-over-year?
- Boston Scientific's debt-to-equity decreased by 94.7% year-over-year, from 0.5× to 0×.
- What is the long-term trend for Boston Scientific's debt-to-equity?
- Over 5 years (2020 to 2025), Boston Scientific's debt-to-equity has grown at a -46.5% compound annual growth rate (CAGR), from 0.6× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Boston Scientific's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude